Ataxia-telangiectasia
📧 Sign up to get email alerts when something new happens for Ataxia-telangiectasia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: The Pancreas Interception Center (PIC) for Early Detection, Prevention, and Novel Therapeutics
This clinical trial update outlines the Pancreas Interception Center (PIC) focused on early detection, prevention, and novel therapeutics fo…
-
CLINICAL_TRIALS trial_result · 2026-03-25Clinical Trial Update: N-Acetyl-L-Leucine for Ataxia-Telangiectasia (A-T) [Phase 2]
A Phase 2 study of N-acetyl-L-leucine for Ataxia-Telangiectasia was terminated, with results posted.
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: Open-Label Extension of EryDex Study IEDAT-04-2022 [Phase 3]
A Phase 3 open-label extension of EryDex for Ataxia Telangiectasia has been terminated.
-
CLINICAL_TRIALS trial_result · 2026-02-24Clinical Trial Update: Expanded Access Program (EAP) of Levacetylleucine for Ataxia-Telangiectasia (A-T)
IntraBio reports that an Expanded Access Program for Levacetylleucine is available for patients with Ataxia-Telangiectasia.
-
CLINICAL_TRIALS trial_result · 2026-01-13Clinical Trial Update: Evaluate the Neurological Effects of EryDex on Subjects With A-T [Phase 3]
Phase 3 trial evaluating the neurological effects of EryDex in people with Ataxia Telangiectasia has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-10-10Clinical Trial Update: Safety and Efficacy of Mutation-targeted Precision Genetic Therapy for Ataxia-Telangiectasia (A-T) [Phase 1, Phase 2]
Clinical trial update on a mutation-targeted precision genetic therapy for Ataxia-telangiectasia (Phase 1/Phase 2), currently not recruiting…
-
CLINICAL_TRIALS research · 2025-07-03Clinical Trial Update: A Pivotal Study of N-Acetyl-L-Leucine on Ataxia-Telangiectasia (A-T) [Phase 3]
A pivotal Phase 3 study evaluating N-Acetyl-L-Leucine for Ataxia-Telangiectasia is active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2024-10-10Clinical Trial Update: Intra-Erythrocyte Dexamethasone Sodium Phosphate in Ataxia Teleangiectasia Patients [Phase 2]
A Phase 2 study evaluating intra-erythrocyte dexamethasone sodium phosphate in patients with ataxia-telangiectasia has completed and posted …
-
CLINICAL_TRIALS trial_result · 2024-10-08Clinical Trial Update: Extension Treatment Using EryDex System in Patients With AT Who Participated in the ATTeST-IEDAT-02-2015 Study [Phase 3]
This update reports that the Phase 3 extension study of EryDex System in patients with Ataxia Telangiectasia has been terminated, with resul…
-
CLINICAL_TRIALS trial_result · 2024-05-09Clinical Trial Update: Intra-Erythrocyte Dexamethasone Sodium Phosphate in Ataxia Telangiectasia Patients [Phase 3]
A Phase 3 clinical trial evaluating intra-erythrocyte dexamethasone sodium phosphate in patients with Ataxia Telangiectasia has completed an…
-
CLINICAL_TRIALS research · 2023-07-20Clinical Trial Update: Ataxia-telangiectasia: Treating Mitochondrial Dysfunction With a Novel Form of Anaplerosis [Phase 2]
Phase 2 clinical trial investigating a novel form of anaplerosis to treat mitochondrial dysfunction in Ataxia-telangiectasia.
-
CLINICAL_TRIALS trial_result · 2022-08-17Clinical Trial Update: NAD Supplementation to Prevent Progressive Neurological Disease in Ataxia Telangiectasia [Phase 2]
Phase 2 clinical trial evaluating NAD supplementation to prevent progressive neurological disease in Ataxia Telangiectasia.
-
CLINICAL_TRIALS trial_result · 2022-07-25Clinical Trial Update: Effects of Vitamin B3 in Patients With Ataxia Telangiectasia [Phase 2]
Phase 2 trial update examining the effects of vitamin B3 in patients with Ataxia Telangiectasia due to ATM gene mutation.
-
CLINICAL_TRIALS trial_result · 2021-05-17Clinical Trial Update: MBM-01 (Tempol) for the Treatment of Ataxia Telangiectasia [Phase 2]
Phase 2 clinical trial update for MBM-01 (Tempol) in Ataxia Telangiectasia (including children).
-
CLINICAL_TRIALS trial_result · 2017-12-04Clinical Trial Update: Response of Individuals With Ataxia-Telangiectasia to Metformin and Pioglitazone [Phase 4]
Phase 4 clinical trial assessing the response of individuals with Ataxia-Telangiectasia to metformin and pioglitazone has completed.
-
CLINICAL_TRIALS trial_result · 2017-11-30Clinical Trial Update: Susceptibility to Infections in Ataxia Telangiectasia [NA]
Clinical trial investigating susceptibility to infections in Ataxia Telangiectasia has completed.
-
CLINICAL_TRIALS research · 2017-11-30Clinical Trial Update: Susceptibility to Infections, Tumor Risk and Liver Disease in Patients With Ataxia Telangiectasia [NA]
This clinical trial update examines susceptibility to infections, tumor risk, and liver disease in patients with Ataxia Telangiectasia.
-
CLINICAL_TRIALS trial_result · 2015-08-27Clinical Trial Update: Study for Treatment of Cancer in Children With Ataxia-telangiectasia [NA]
Clinical trial update for a study aiming to treat cancer in children with Ataxia-Telangiectasia; the study is listed as completed with no dr…
-
CLINICAL_TRIALS research · 2015-01-26Clinical Trial Update: Body Composition and Hormonal Status in Ataxia Telangiectasia [NA]
This is a clinical trial update for a study on body composition and hormonal status in people with Ataxia Telangiectasia, which has complete…
-
CLINICAL_TRIALS trial_result · 2014-12-31Clinical Trial Update: International Ataxia Rating Scale in Younger Patients
This entry reports a completed clinical trial evaluating the International Ataxia Rating Scale in younger patients with Ataxia Telangiectasi…
-
CLINICAL_TRIALS trial_result · 2011-06-28Clinical Trial Update: Amantadine for Improving Neurologic Symptoms in Ataxia-Telangiectasia [Phase 4]
Phase 4 trial evaluating amantadine for neurologic symptoms in Ataxia-telangiectasia has completed.
-
CLINICAL_TRIALS trial_result · 2010-07-05Clinical Trial Update: Status of Growth Hormone/ Insulin-like Growth Factor-1 (GH/IGF-1) Axis and Growth Failure in Ataxia Telangiectasia (AT) [Phase 4]
This Phase 4 clinical trial investigates the GH/IGF-1 axis and growth failure in patients with Ataxia Telangiectasia; the current status of …
-
CLINICAL_TRIALS research · 2010-03-16Clinical Trial Update: Immunogenicity of Pneumococcal Vaccines in Ataxia-telangiectasia Patients
A clinical trial is evaluating the immunogenicity of pneumococcal vaccines in patients with Ataxia Telangiectasia. The current status and re…
-
CLINICAL_TRIALS research · 2009-08-04Clinical Trial Update: The Validity of Forced Expiratory Maneuvers in Ataxia Telangiectasia Studied Longitudinally
A longitudinal clinical trial update examining the validity of forced expiratory maneuvers in patients with Ataxia Telangiectasia.
-
CLINICAL_TRIALS trial_result · 2008-04-11Clinical Trial Update: Conjugate Pneumococcal Vaccine in Ataxia Telangiectasia (AT) [Phase 3]
A Phase 3 clinical trial evaluating a conjugate pneumococcal vaccine in patients with Ataxia Telangiectasia has completed.